Yonghe Medical: It is expected to have a net profit of about 11 million yuan to 20 million yuan in the first half of 2022

On July 29, 2022, Yonghe Medical (Code: 02279.HK), a listed company of Hong Kong stocks, released the 2022 financial annual report performance preview. As of June 30, 2022, the performance declined sharply, and the expected income was about 6.73 From 100 million yuan to RMB 823 million, the revenue of about six months ended June 30, 2021 was approximately RMB 1.053 billion; gross profit was about RMB 432 million to RMB 529 million. The six -month gross profit was about RMB 775 million; the net profit was about RMB 11 million to RMB 20 million, and the net profit of the six months ended June 30, 2021 was approximately RMB 40.4 million.

The company's industry is a health care institution.

The company made the above prediction based on the following reasons: The expected reduction is mainly due to (including) the following reasons (i) for six months as of June 30, 2022, and the Group's more than 30 medical institutions have suspended / restricted operations. However, such medical institutions still generate fixed operating costs such as rent and employee salary; and (ii) is optimistic about the prospects of China's hair medical service market, the group still adheres to its expansion plan, so it has generated additional expansion related expenses. As of June 30, 2022, the Group has completed the construction of 12 new stores, and 19 new stores are under construction. The Group believes that the construction of these new stores will help the Group's future business performance and strategic planning development.

Yonghe Medical Group Co., Ltd. was established on September 17, 2020. The company adopts a standardized and scalable business model to operate chain hair transplant medical institutions based on self -operated medical institutions. According to the information of Fhstana, as of the last actual possible date, the company has operated 53 medical institutions in 52 cities across the country to be the largest and most widely covered chain hair transplant medical institution in China. During the trading record, the company opened 29 new medical institutions in Mainland China and acquired a medical institution in Hong Kong. The scale of the largest growth in all chain hair transplant medical institutions in China has achieved the fastest growth, which is far more than the industry's second place.

- END -